High efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study

Affiliation auteurs!!!! Error affiliation !!!!
TitreHigh efficacy and safety of grazoprevir and elbasvir for 8 weeks in treatment-naive, non-severe fibrosis HCV GT1b-infected patients: Interim Results of the STREAGER Study
Type de publicationJournal Article
Year of Publication2018
AuteursAbergel A., Hezode C., Asselah T., Larrey D., Gournay J., Loustaud-Ratti V., Martino V.D, Hubert I.F, Samuel D., Chanteranne B., Dodel M., Faure F., Pereira B., Lamblin G., Campos C., Muti L., Reymond M., Teilhet C.
JournalJOURNAL OF HEPATOLOGY
Volume68
PaginationS110
Date PublishedAPR
Type of ArticleMeeting Abstract
ISSN0168-8278
DOI10.1016/S0168-8278(18)30437-9